IP Library Granted Patent US 10,240,202
Granted Patent B2
US 10,240,202 · App. 15/191,197 · Granted Mar 26, 2019

System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals

Inventors: Matthew Rabinowitz (San Francisco, CA); Milena Banjevic (Los Altos Hills, CA); Zachary Demko (San Francisco, CA); David Johnson (San Francisco, CA)
Assignee: Natera, Inc.
C12Q1/6883C12Q1/6827C12Q1/6876G06F19/18G06F19/20G06F19/22G06F19/24C12Q2600/118C12Q2600/156C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,240,202
App. No.
15/191,197
Granted
Mar 26, 2019
Kind
B2
Abstract

A system and method for determining the genetic data for one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available, are disclosed. Genetic data for the target individual is acquired and amplified using known methods, and poorly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related subjects. In accordance with one embodiment of the invention, incomplete genetic data is acquired from embryonic cells, fetal cells, or cell-free fetal DNA isolated from the mother's blood, and the incomplete genetic data is reconstructed using the more complete genetic data from a larger sample diploid cells from one or both parents, with or without genetic data from haploid cells from one or both parents, and/or genetic data taken from other related individuals.

Claims (26)

1. A method for detecting aneuploidy in a fetus, the method comprising:

(a) measuring the amounts of genetic material at multiple loci on a chromosome or chromosome segment of interest in a sample comprising cell-free DNA derived from the fetus and from the mother of the fetus, wherein the measuring comprises amplifying at least 70 loci in a single reaction and using microarray or sequencing to detect amplified reaction products, and wherein the amount of genetic material at a particular locus is determined irrespective of the identity of the alleles at that locus;

(b) determining, on a computer, the probability of aneuploidy in the fetus by comparing the measured amounts of genetic material to an expected amount for a particular copy number; and

(c) outputting the selected probability as an indication of whether the fetus has aneuploidy.

2. The method of claim 1 , wherein the determining is performed by comparing the amount from step (a) to an expected amount, wherein the expected amount is a mean value of genetic material at multiple loci for a reference chromosome or chromosome segment that is present in two copies.

3. The method of claim 1 , wherein a microarray is used to measure the amount of genetic material at the multiple loci.

4. The method of claim 1 , wherein the amount of genetic material for at least 70 loci is measured by performing a multiplex amplification in a single reaction, and wherein a microarray is used to detect the amplified reaction products.

5. The method of claim 4 , wherein the method comprises a PCR amplification using universal amplification sequences, and wherein the multiplex amplification reaction and/or the PCR reaction comprise a ligation PCR reaction.

6. The method of claim 4 , wherein the multiple loci are loci having alleles with 100% penetrance in the population.

7. The method of claim 1 , wherein the sample comprises cell-free DNA isolated from blood from the mother of the fetus.

8. The method of claim 1 , wherein the chromosome of interest or the chromosome comprising the chromosome segment of interest is selected from the group consisting of chromosome 13, chromosome 18, chromosome 21, X chromosome, Y chromosome, and combinations thereof.

9. The method of claim 1 , wherein the amount of genetic material for at least 70 loci is measured by performing a multiplex amplification in a single reaction, wherein the method further comprises a PCR amplification using universal amplification sequences, wherein the multiplex amplification and PCR reaction comprise ligating oligonucleotides that hybridize to target sequences and amplifying the ligated oligonucleotides using PCR, and wherein a microarray is used to detect the amplified reaction products.

10. The method of claim 9 , wherein the multiplex amplification reaction and the ligation PCR reaction are performed in an Illumina Golden Gate assay.

11. The method of claim 1 , wherein the multiple loci on the chromosome or chromosome segment of interest comprise between 32 and 2002 loci.

12. The method of claim 8 , wherein the multiple loci on the chromosome or chromosome segment of interest comprise between 70 and 2002 loci.

13. A method for detecting aneuploidy in a fetus, the method comprising:

(a) measuring an amount of genetic material at multiple loci on a chromosome or chromosome segment of interest in a sample comprising cell-free DNA from the fetus and cell-free DNA from the mother of the fetus, wherein the measuring comprises amplifying at least 70 loci in a single reaction and using microarray or sequencing to detect amplified reaction products, and wherein the amount of genetic material at a particular locus is measured irrespective of the identity of the alleles at that locus;

(b) determining, on a computer, the probability of aneuploidy in the fetus by comparing the measured amounts of genetic material to an expected amount for a particular copy number hypothesis, wherein the expected amount is determined using a mean value of genetic material at multiple loci for a reference chromosome or chromosome segment that is present in two copies; and

(c) selecting a particular copy number with greatest probability, thereby detecting aneuploidy if present.

14. The method of claim 13 , wherein the method further comprises using data from a method that makes use of allele calls at a plurality of single nucleotide polymorphism loci to determine the probability of a particular copy number hypothesis.

15. The method of claim 13 , wherein a microarray is used to measure the amount of genetic material at the multiple loci and wherein the sample comprises cell-free DNA isolated from blood from the mother of the fetus.

16. The method of claim 13 , wherein the chromosome of interest or the chromosome comprising the chromosome segment of interest is selected from the group consisting of chromosome 13, chromosome 18, chromosome 21, X chromosome, Y chromosome, and combinations thereof.

17. The method of claim 13 , wherein the multiple loci on the chromosome or chromosome segment of interest comprise between 9 and 2002 loci.

18. The method of claim 13 , wherein the amount of genetic material is measured for alleles at each of the multiple loci that have 100% penetrance in the population.

19. The method of claim 18 , wherein the multiple loci on the chromosome or chromosome segment of interest comprise between 70 and 2002 loci.

20. The method of claim 13 , wherein the selecting comprises calculating an odds ratio using the probabilities for each copy number hypothesis.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 22, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: NATERA, INC.
Reel/Frame 052472/0712 →
SECURITY INTEREST Recorded Aug 8, 2017
From: NATERA, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 043482/0472 →
CHANGE OF NAME Recorded Oct 10, 2016
From: GENE SECURITY NETWORK INC.
To: NATERA, INC.
Reel/Frame 040295/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2016
From: RABINOWITZ, MATTHEW; BANJEVIC, MILENA; DEMKO, ZACHARY PAUL; JOHNSON, DAVID SCOTT
To: GENE SECURITY NETWORK, INC.
Reel/Frame 039977/0070 →
Continuity (5)
Continuation 13793133 · Mar 11, 2013
Continuation 11603406 · Nov 22, 2006
Provisional Application 60846610 · Sep 22, 2006
Provisional Application 60739882 · Nov 26, 2005
Related Publication 20160369345A1 · Dec 22, 2016
Cited By (38)
US 12,195,803 US 12,203,142 US 12,209,281 US 12,221,653 US 12,234,509 US 12,252,743 US 12,260,934 US 12,270,073 US 12,305,229 US 12,305,235 US 12,385,096 US 12,410,476 US 12,442,038 US 12,460,264 US 12,486,542 US 12,492,429 US 12,494,267 US 12,509,728 US 12,509,730 US 12,518,859 US 12,534,759 US 12,545,960 US 12,553,082 US 12,553,083 US 12,553,086 US 12,553,087 US 12,571,034 US 12,571,043 US 12,571,047 US 12,584,175 US 12,644,149 US 12,649,946 US 12,655,483 US 12,662,704 US 12,668,843 US 12,692,544 US 12,716,090 US 12,716,100